Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
18,656.00
+81.00
+(0.44%)
At close: February 28 at 1:24:21 PM CST
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
8,817,900
8,817,900
4,240,100
7,585,700
7,365,900
Investing Cash Flow
-9,301,500
-9,301,500
-7,152,700
-3,762,900
-2,867,500
Financing Cash Flow
1,230,100
1,230,100
3,495,600
-5,406,700
-4,131,300
End Cash Position
3,268,400
3,268,400
2,818,600
2,067,000
3,818,500
Capital Expenditure
-8,403,600
-8,403,600
-7,392,100
-2,985,300
-1,978,400
Issuance of Debt
11,417,100
11,417,100
3,958,500
--
2,410,800
Repayment of Debt
-664,200
-664,200
--
-1,560,000
-1,905,400
Repurchase of Capital Stock
-2,500,000
-2,500,000
-750,000
-1,500,000
-1,250,000
Free Cash Flow
414,300
414,300
-3,152,000
4,600,400
5,387,500
12/31/2021 - 3/1/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4AB.F AbbVie Inc.
197.68
+2.16%
BRM.MU Bristol-Myers Squibb Co
56.83
+3.29%
PFE.HM Pfizer Inc
24.94
-0.82%
PFE.HA Pfizer Inc
24.94
-0.82%
D4S.MU Daiichi Sankyo Co Ltd
22.27
-0.45%
PFE.BE Pfizer Inc
25.02
-0.24%
PFE.MU Pfizer Inc
24.92
-0.91%
PFE.SG Pfizer Inc
25.04
-0.30%
ABBV34.SA AbbVie Inc.
76.22
+2.32%
BRM.F Bristol-Myers Squibb Company
55.92
-0.85%